Login to Your Account

Morphosys Gets $114M to Fund Antibody Programs

By Cormac Sheridan
Staff Writer

Wednesday, September 25, 2013
Morphosys AG raised 84 million (US$114 million) in a private placement, adding another hefty chunk of change to what is already a robust balance sheet.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription